what happens if i inject too much semaglutide Poison centers see nearly 1,500% increase in calls related to injected weight-loss drugs as people accidentally overdose What to Do If You

Clinical trials hold each dose for four weeks before escalation, and this is not arbitrary

Hope DCD, Vincent ML, Tan TMM

Disease modifying agents capable of controlling obesity with meaningful metabolic improvement have reshaped expectations for both clinicians and patients ( Nausea and vomiting remain among the most frequent and disruptive adverse effects across Glucagon-like peptide (GLP-1)-based therapies ( In this opinion article, we examine the mechanisms underlying nausea and vomiting in semaglutide, CagriSema, survodutide, tirzepatide, retatrutide, and orforglipron and situate them within obesity clinical practice ( We also propose practical strategies to mitigate gastrointestinal intolerance

Post hoc comparisons were appraised using the conservative Bonferroni/Dunn test

Stenzel, W., Soltek, S., Schluter, D